ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

Clinical trial NCT06733922 · RECRUITING

Trial details

NCT number: NCT06733922
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis (RRMS)

Start date: 2024-11-27
Primary completion: 2028-11-30
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.